Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220974085
Abstract: Introduction Cancer patients receiving myelosuppressive chemotherapy are vulnerable to febrile neutropenia (FN) which contributes to poor treatment outcomes. The use of granulocyte colony-stimulating factors is administered to prevent chemotherapy-induced neutropenia. The introduction of biosimilars has…
read more here.
Keywords:
reference biologic;
review;
reference;
pegfilgrastim ... See more keywords